Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2580-2584

  Prodinger, Wolfgang M ^a   Larcher, Clara ^a   Schwendinger, Michael ^a   Dierich, Manfred P ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; MEMBRANE RECEPTOR;

ANTIBODY DETECTION; ARTICLE; BINDING SITE; CELL TRANSFORMATION; COMPLEX FORMATION; CROSS LINKING; GERMINAL CENTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RADIOIMMUNOPRECIPITATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CELL LINE; CELL LINE, TRANSFORMED; COMPLEMENT C3D; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LIGANDS; MACROMOLECULAR SUBSTANCES; PRECIPITIN TESTS; RECEPTORS, COMPLEMENT 3D; T-LYMPHOCYTES;

EID: 0029880777     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Cooper, N. R., M. D. Moore, and G. R. Nemerow. 1988. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. Annu. Rev. Immunol. 6:85.
2. Ahearn, J. M., and D. T. Fearon. 1989. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:183.
3. Reid, K. B. M., D. R. Bentley, R. D. Campbell, L. P. Chung, R. B. Sim, T. Kristensen, and B. F. Tack. 1986. Complement system proteins which interact with C3b or C4b. Immunol. Today 7:230.
4. Reid, K. B. M., and A. J. Day. 1989. Structure-function relationship of the complement components. Immunol. Today 10:177.
5. Iida, K., L. Nadler, and V. Nussenzweig. 1983. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J. Exp. Med. 158:1021.
6. Weis, J. J., T. F. Tedder, and D. T. Fearon. 1984. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 81:881.
7. Ross, G. D., M. J. Polley, E. M. Rabellino, and H. M. Grey. 1973. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator cleaved C3b. J. Exp. Med. 138:798.
8. Tedder, T. F., L. T. Clement, and M. D. Cooper. 1984. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133:678.
9. Fischer, E., C. Delibrias, and M. D. Kazatchkine. 1991. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146:865.
10. Tsoukas, D. C., and J. D. Lambris. 1988. Expression of CR2/EBV-receptors on human thymocytes detected by monoclonal antibodies. Eur. J. Immunol. 18:1299.
11. Larcher, C., T. F. Schulz, J. Hofbauer, P. Hengster, N. Romani, H. Wachter, and M. P. Dierich. 1990. Expression of the C3d/EBV receptor and other cell membrane surface markers is altered upon HIV-1 infection of myeloid, T, and B cells. J. AIDS 3:103.
12. Kai, C., N. Okada, and H. Okada. 1988. Expression of CR2 (C3d receptor) on the cell membranes of adult T cell leukemia. Jpn. J. Cancer Res. 79:805.
13. Delibrias, C.-C., E. Fischer, G. Bismuth, and M. D. Kazatchkine. 1992. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL. J. Immunol. 149: 768.
14. Young, L. S., J. W. Sixbey, D. Clark, and A. B. Rickinson. 1986. Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet 1:240.
15. Birkenbach, M., X. Tong, L. E. Bradbury, T. F. Tedder, and E. Kieff. 1992. Characterization of an Epstein-Barr virus receptor on human epithelial cells. J. Exp. Med. 176:1405.
16. Reynes, M., J. P. Aubert, and M. D. Kazatchkine. 1985. Human follicular dendritic cells express CR1, CR3, and CR2 complement receptor antigens. Fed. Proc. 44:562.
17. Hedrick, J. A., Z. Lao, S. G. Lipps, Y. Wang, S. C. Todd, J. D. Lambris, and C. D. Tsoukas. 1994. Characterization of a 70-kDa, EBV gp350/220-binding protein on HSB-2 T cells. J. Immunol. 153:4418.
18. Tanner, J., J. Weis, D. Fearon, Y. Whang, and E. Kieff. 1987. EBV gp 350/220 binding to the B lymphocyte C3d receptor mediates absorption, capping, and endocytosis. Cell 50:203.
19. Melchers, F., A. Erdei, T. Schulz, and M. P. Dierich. 1985. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 317:264.
20. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B-lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13: 127.
21. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lympbocyte-coutaining complement receptor type 2 and CD19. J. Exp. Med. 173:55.
22. Matsumoto, A. K., D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn, and D. T. Fearon. 1993. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407.
23. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149: 2841.
24. Bradbury, L. E., V. S. Goldmacher, and T. F. Tedder. 1993. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu-13. J. Immunol. 151:2915.
25. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffmann, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457.
26. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
27. Tuveson, D. A., J. M. Ahearn, A. K. Matsumoto, and D. T. Fearon. 1991. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex. J. Exp. Med. 173:1083.
28. McNearney, T. A., C. F. Ebenbichler, M. Tötsch, and M. P. Dierich. 1993. Expression of complement receptor 2 (CR2) on HTLV-I infected lymphocytes and transformed cell lines. Eur. J. Immunol. 23:1266.
29. Carel, J.-C., B. L. Myones, B. Frazier, and V. M. Holers. 1990. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization and viral infection. J. Biol. Chem. 265:12293.
30. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 133: 123.
31. Aubry, J.-P., S. Pochon, J. F. Gauchat, A. Nueda-Marin, V. M. Holers, P. Graber, C. Siegfried, and J.-Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 152:5806.
32. Mehta, S., S. Grant, R. Sandler, S. Sharma, J. Morgan, N. Kouttab, C. Sahasrabuddhe, and A. Maizel. 1986. Bichemical characterization of human B-cell growth factor receptor. Fed. Proc. 45:494.
33. Berger, P., W. Panmoung, D. Khaschabi, B. Mayregger, and G. Wick. 1988. Antigenic features of human follicle stimulating hormone delineated by monoclonal antibodies and construction of an immunoradiometric assay. Endocrinology 123:2351.
34. Thompson, J. A., A. L. Lau, and D. D. Cunningham. 1987. Selective radiolabeling of cell surface proteins to a high specific activity. Biochemistry 26:743.
35. Crabtree, G. R., and N. A. Clipstone. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 53:1045.
36. Barel, M., M. Blabo, A. Gaufire, and R. Frade. 1995. Binding sites of the Epstein-Barr virus and C3d receptor (CR2,CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein. Mol. Immunol. 32:389.
37. Sinha, S. K., S. C. Todd, J. A. Hedrick, C. L. Speiser, J. D. Lambris, and C. D. Tsoukas. 1993. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript. J. Immunol. 150:5311.
38. Levy, E., J. Ambras, L. Kahl, H. Molina, K. Tung, and V. M. Holers. 1992. T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and deregulation in a patient with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 90:235.
39. Larcher, C., B. Kempkes, E. Kremmer, W. M. Prodinger, M. Pawlita, G. W. Bornkamm, and M. P. Dierich. 1995. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21. Eur. J. Immunol. 25:1713.
40. Luxembourg, A., and N. R. Cooper. 1994. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153: 4448.
41. Kim, K. M., T. Adachi, P. J. Nielsen, M. Terashima, M. C. Lamers, G. Köhler, and M. Reth. 1994. Two new proteins preferentially associated with membrane immunoglobulin D. EMBO J. 13:3793.
42. Bonnefoy, J.-Y., J. Shields, and J. J. Mermod. 1990. Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/Fc epsilon RII monoclonal antibodies. Eur. J. Immunol. 20/1:139.
43. Liu, Y.-J., J. A. Cairns, M. J. Holder, S. D. Abbot, K. U. Jansen, J.-Y. Bonnefoy, J. Gordon, and I. C. M. MacLennan. 1991. Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 21:1107.
44. Aubry, J.-P., S. Pochon, P. Graber, K. U. Jansen, and J.-Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505.
45. Bonnefoy, J.-Y., S. Henchoz, D. Hardie, M. J. Holder, and J. Gordon. 1993. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23:969.
46. Henchoz, S., J.-F. Gauchat, J.-P. Aubry, P. Graber, S. Pochon, and J.-Y. Bonnefoy. 1994. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts. Immunology 81:285.
47. Pantazis, P., V. S. Kalyanamaran, and D. H. Bing. 1990. Synthesis of the third component of complement (C3) by the lectin-activated and HTLV-infected human T-cells. Mol. Immunol. 27:283.